Total Payments
$501.42
2024 Payments
$364.23
Companies
11
Transactions
28
Medicare Patients
326
Medicare Billing
$24,242
Payment Breakdown by Category
Food & Beverage$501.42 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $501.42 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $85.53 | 5 | $0 (2024) |
| ABBVIE INC. | $80.10 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $64.18 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $61.69 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $54.88 | 3 | $0 (2024) |
| Lilly USA, LLC | $54.73 | 3 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34.18 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.19 | 1 | $0 (2023) |
| Amgen Inc. | $14.87 | 1 | $0 (2024) |
| Medtronic, Inc. | $14.11 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $364.23 | 20 | ABBVIE INC. ($80.10) |
| 2023 | $137.19 | 8 | Lilly USA, LLC ($35.96) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardio-renal | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Respiratory | ||||||
| 04/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardio-renal | ||||||
| 03/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Inflammation | ||||||
| 03/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: PSYCHIATRY | ||||||
| 02/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: PSYCHIATRY | ||||||
| 01/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Respiratory | ||||||
| 01/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Gastroenterology | ||||||
| 11/29/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Diabetes | ||||||
| 11/27/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/20/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 208 | 249 | $45,329 | $14,507 |
| 2022 | 5 | 118 | 124 | $21,862 | $9,735 |
Total Patients
326
Total Services
373
Medicare Billing
$24,242
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 115 | $21,735 | $7,062 | 32.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 25 | $7,125 | $2,597 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 49 | $6,909 | $2,089 | 30.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $2,728 | $1,123 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,744 | $1,018 | 27.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 11 | 12 | $720.00 | $486.60 | 67.6% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 11 | $2,200 | $84.24 | 3.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 14 | $168.00 | $47.74 | 28.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $12,896 | $5,384 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 25 | $4,725 | $2,013 | 42.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,390 | $959.56 | 69.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $2,256 | $915.20 | 40.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $595.00 | $463.59 | 77.9% |
About Rachel Hewitt, NP
Rachel Hewitt, NP is a Nurse Practitioner healthcare provider based in West Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2022. The National Provider Identifier (NPI) number assigned to this provider is 1255065686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Hewitt, NP has received a total of $501.42 in payments from pharmaceutical and medical device companies, with $364.23 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($501.42).
As a Medicare-enrolled provider, Hewitt has provided services to 326 Medicare beneficiaries, totaling 373 services with total Medicare billing of $24,242. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location West Lafayette, IN
- Active Since 07/12/2022
- Last Updated 09/15/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1255065686
Products in Payments
- Ozempic (Drug) $69.52
- TRELEGY ELLIPTA (Drug) $61.69
- Kerendia (Drug) $54.88
- MOUNJARO (Drug) $54.73
- QULIPTA (Drug) $44.81
- VRAYLAR (Drug) $35.29
- CAPLYTA (Drug) $34.18
- AIRSUPRA (Drug) $29.90
- XIFAXAN (Drug) $23.19
- BREZTRI (Drug) $20.03
- Rybelsus (Drug) $16.01
- Otezla (Drug) $14.87
- FARXIGA (Drug) $14.25
- INTELLIS ADAPTIVESTIM (Device) $14.11
- YUPELRI (Drug) $13.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in West Lafayette
Dr. Mark Manning, Dnp, DNP
Nurse Practitioner — Payments: $7,136
Nurse Practitioner $7,136
Mr. Phillip Deturk, Np, NP
Nurse Practitioner — Payments: $4,332
Nurse Practitioner $4,332
Mrs. Shelley Velickoff, A.n.p, A.N.P
Nurse Practitioner — Payments: $3,431
Nurse Practitioner $3,431
Katrina Masterson, Np, NP
Nurse Practitioner — Payments: $3,264
Nurse Practitioner $3,264
Holly Howe, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $2,573
Nurse Practitioner $2,573
Mrs. Stephanie Davitto, N.p, N.P
Nurse Practitioner — Payments: $2,301
Nurse Practitioner $2,301